Persistent Asset Partners Ltd Invests $3.89 Million in CVS Health Corporation $CVS

Persistent Asset Partners Ltd purchased a new stake in CVS Health Corporation (NYSE:CVS) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 51,542 shares of the pharmacy operator’s stock, valued at approximately $3,886,000. CVS Health makes up approximately 2.7% of Persistent Asset Partners Ltd’s investment portfolio, making the stock its 4th largest holding.

Other institutional investors have also recently bought and sold shares of the company. Harbor Capital Advisors Inc. boosted its holdings in CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares during the last quarter. Avion Wealth raised its holdings in CVS Health by 99.0% during the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 189 shares in the last quarter. Corundum Trust Company INC acquired a new position in CVS Health during the third quarter valued at approximately $29,000. Front Row Advisors LLC grew its stake in CVS Health by 436.5% in the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 371 shares in the last quarter. Finally, SOA Wealth Advisors LLC. increased its position in shares of CVS Health by 36.9% during the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock worth $37,000 after purchasing an additional 131 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on the stock. Robert W. Baird increased their price target on shares of CVS Health from $82.00 to $92.00 and gave the company an “outperform” rating in a research note on Wednesday, December 10th. Mizuho raised their target price on shares of CVS Health from $88.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, December 10th. Evercore upped their price objective on CVS Health from $85.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of CVS Health in a report on Wednesday, December 10th. Finally, Morgan Stanley increased their price objective on shares of CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a research report on Wednesday, December 10th. Nineteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and an average target price of $94.91.

CVS Health Price Performance

CVS Health stock opened at $77.35 on Friday. The stock’s fifty day moving average price is $78.58 and its two-hundred day moving average price is $76.57. The firm has a market cap of $98.40 billion, a PE ratio of 56.05, a price-to-earnings-growth ratio of 0.81 and a beta of 0.50. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.84 and a quick ratio of 0.63. CVS Health Corporation has a one year low of $58.35 and a one year high of $85.15.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. The firm had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The business’s revenue for the quarter was up 8.2% on a year-over-year basis. During the same period in the prior year, the company posted $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. As a group, research analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. The ex-dividend date was Thursday, January 22nd. CVS Health’s dividend payout ratio is currently 192.75%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.